Takeover
Novo goes public with €2.6 billion bid to pressure Belgium's Ablynx
Ghent-based Ablynx has rebuffed offer that includes €28 a share plus cash payments
Danish drugmaker Novo Nordisk made its largest takeover offer ever, an unsolicited €2.6 billion bid for Belgium's Ablynx, to beef up its lesser known blood-disorder unit and rekindle growth.
The offer for Ablynx signals a higher appetite for deals at the world's biggest maker of diabetes medicines.
To keep reading
please sign up for free!
Already have an account? Sign in here.
Editor's Picks
Rental
—
22.01.2019
UK firms to take over entire blocks of flats in Luxembourg for Brexit staff
Mobility
—
21.01.2019
Luxembourg ticket inspectors' jobs safe despite free transport
Exclusive
—
18.01.2019
Luxembourg City needs a second free international school, says education minister
Contingency
—
17.01.2019
Luxembourg steps up no-deal Brexit planning
